Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pike

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|August 27, 2010
Larger temporal volume in elderly with high versus low beta-amyloid depositionGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's diseaseVictor L Villemagne, Keyla A Perez, Kerryn E Pike, et al.
Neuro-Oncology Advances|September 22, 2025
A randomized controlled trial of a telehealth group cognitive intervention (LaTCH-BRAINS) to improve cognition after primary brain tumor diagnosisKerryn E Pike, Sian E B Virtue-Griffiths, Rachel Campbell, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Medicinal Chemistry|April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profileAshok Arasappan, Angela I Padilla, Edwin Jao, et al.
Annals of Neurology|February 1, 2011
Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseVictor L Villemagne, Kerryn E Pike, Gaël Chételat, et al.
Molecular Psychiatry|October 24, 2012
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's diseaseG Verdile, S M Laws, D Henley, et al.
Seminars in Oncology Nursing|July 24, 2024
Impact of Cognitive Rehabilitation on Cognitive and Functional Outcomes in Adult Cancer Survivors: A Systematic ReviewZev M Nakamura, Nadeen T Ali, Adele Crouch, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|August 27, 2010
Larger temporal volume in elderly with high versus low beta-amyloid depositionGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's diseaseVictor L Villemagne, Keyla A Perez, Kerryn E Pike, et al.
Neuro-Oncology Advances|September 22, 2025
A randomized controlled trial of a telehealth group cognitive intervention (LaTCH-BRAINS) to improve cognition after primary brain tumor diagnosisKerryn E Pike, Sian E B Virtue-Griffiths, Rachel Campbell, et al.
Neuropsychologia|March 18, 2008
Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's diseaseV L Villemagne, K E Pike, D Darby, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Medicinal Chemistry|April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profileAshok Arasappan, Angela I Padilla, Edwin Jao, et al.
Annals of Neurology|February 1, 2011
Longitudinal assessment of Aβ and cognition in aging and Alzheimer diseaseVictor L Villemagne, Kerryn E Pike, Gaël Chételat, et al.
Molecular Psychiatry|October 24, 2012
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's diseaseG Verdile, S M Laws, D Henley, et al.
Seminars in Oncology Nursing|July 24, 2024
Impact of Cognitive Rehabilitation on Cognitive and Functional Outcomes in Adult Cancer Survivors: A Systematic ReviewZev M Nakamura, Nadeen T Ali, Adele Crouch, et al.
Pageof 13